Frontotemporal lobar degeneration: Current knowledge and future challenges

Journal of Neurology

Volumn 259, Issue 11, 2012, Pages 2278-2286

  Cerami, Chiara ^a   Scarpini, Elio ^b   Cappa, Stefano F ^a   Galimberti, Daniela ^b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

C9ORF72; Frontotemporal lobar degeneration; Genetics; Progranulin (GRN); Risk factor; Tau

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN; PROGRANULIN; TAU PROTEIN;

AUTOPSY; CHROMOSOME 9; DISEASE TRANSMISSION; FRONTOTEMPORAL DEMENTIA; GENE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; ONSET AGE; OPEN READING FRAME; PHENOTYPE; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; REVIEW;

ANIMALS; FORECASTING; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; MICROTUBULES; MUTATION;

EID: 84868204382     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6507-5     Document Type: Review

References (103)

1. Rosen HJ, Allison SC, Ogar JM, Amici S, Rose K, Dronkers N et al (2006) Behavioral features in semantic dementia vs other forms of progressive aphasias. Neurology 67:1752-1756 (Pubitemid 44900748)
2. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M et al (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51:1546-1554
3. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134:2456-2477
4. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF et al (2011) Classification of primary progressive aphasia and its variants. Neurology 76:1006-1014
5. Piguet O, Hornberger M, Mioshi E, Hodges JR (2011) Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management. Lancet Neurol 10:162-172
6. Scarpini E, Galimberti D, Guidi I, Bresolin N, Scheltens P (2006) Progressive, isolated language disturbance: its significance in a 65 year-old-man. A case report with implications for treatment and review of literature. J Neurol Sci 240:45-51 (Pubitemid 41814952)
7. Rankin KP, Kramer JH, Miller BL (2005) Patterns of cognitive and emotional empathy in frontotemporal lobar degeneration. Cogn Behav Neurol 18:28-36 (Pubitemid 40381367)
8. Rankin KP, Gorno-Tempini ML, Allison SC, Stanley CM, Glenn S, Weiner MW, Miller BL (2006) Structural anatomy of empathy in neurodegenerative disease. Brain 129:2945-2956 (Pubitemid 44684515)
9. Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, Phengrasamy L, Rosen HJ et al (2004) Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 55:335-346 (Pubitemid 38269585)
10. Gorno-Tempini ML, Brambati SM, Ginex V, Ogar J, Dronkers NF, Marcone A et al (2008) The logopenic/phonological variant of primary progressive aphasia. Neurology 71:1227-1234
11. Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC et al (2008) Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 64:388-401
12. Ratnavalli E, Brayne C, Dawson K, Hodges JR (2002) The prevalence of frontotemporal dementia. Neurology 58:1615-1621 (Pubitemid 34602891)
13. Bird T, Knopman D, VanSwieten J, Rosso S, Feldman H, Tanabe H, Graff-Raford N, Geschwind D, Verpillat P, Hutton M (2003) Epidemiology and genetics of frontotemporal dementia/Pick's disease. Ann Neurol 54:S29-S31 (Pubitemid 36760151)
14. Goldman JS, Farmer JM, Wood EM, Johnson JK, Boxer A, Neuhaus J et al (2005) Comparison of family histories in FTLD subtypes and related tauopathies. Neurology 65:1817-1819
15. Snowden JS, Neary D, Mann DM (2002) Frontotemporal dementia. Br J Psychiatry 180:140-143 (Pubitemid 34142785)
16. Pickering-Brown SM (2007) The complex aetiology of fronto-temporal lobar degeneration. Exp Neurol 114:39-47 (Pubitemid 47029058)
17. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245-256
18. Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257-268
19. Gijselinck I, Van Langenhove T, van der Zee J, Sleegers K, Philtjens S, Kleinberger G et al (2012) A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol 11(1):54-65
20. Lynch T, Sano M, Marder KS, Bell KL, Foster NL, Defendini RF et al (1994) Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amy-otrophy complex. Neurology 44:1878-1884 (Pubitemid 24319215)
21. 0-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702-705
22. Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, Andreadis A et al (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 43:815-825 (Pubitemid 28280226)
23. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 95:7737-7741 (Pubitemid 28293323)
24. Ingram EM, Spillantini MG (2002) Tau gene mutations: dissecting the pathogenesis of FTDP-17. Trends Mol Med 8:555-562 (Pubitemid 35408213)
25. Rademakers R, Cruts M, van Broeckhoven C (2004) The role of tau (MAPT) in frontotemporal dementia and related tauopathies. Hum Mutat 24:277-295 (Pubitemid 39336634)
26. Rademakers R, Cruts M, Dermaut B, Sleegers K, Rosso SM, Van den Broeck M et al (2002) Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval. Mol Psychiatry 7:1064-1074 (Pubitemid 36044265)
27. Goedert M, Jakes R (2005) Mutations causing neurodegenerative tauopathies. Biochim Biophys Acta 1739:240-250 (Pubitemid 40021808)
28. Buée L, Delacourte A (1999) Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol 9:681-693 (Pubitemid 29470961)
29. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 3:519-526
30. Yancopoulou D, Spillantini MG (2003) Tau protein in familial and sporadic diseases. Neuromol Med 4:37-48 (Pubitemid 37315184)
31. Villa C, Ghezzi L, Pietroboni AM, Fenoglio C, Cortini F, Serpente M et al (2011) A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia. J Alz-heimers Dis 26:19-26
32. van Swieten J, Spillantini MG (2007) Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol 17:63-73
33. van Swieten JC, Heutink P (2008) Mutations in progranulin (GRN) within the spectrum of clinical and pathological pheno-types of frontotemporal dementia. Lancet Neurol 7:965-974
34. Boeve BF, Hutton M (2008) Refining frontotemporal dementia with parkinsonism linked to chromosome 17: introducing FTDP-17 (MAPT) and FTDP-17 (PGRN). Arch Neurol 65:460-464 (Pubitemid 351549953)
35. Josephs KA, Whitwell JL, Knopman DS, Boeve BF, Vemuri P, Senjem ML et al (2009) Two distinct subtypes of right temporal variant frontotemporal dementia. Neurology 73:1443-1450
36. Lendon CL, Lynch T, Norton J, McKeel DW Jr, Busfield F, Craddock N et al (1998) Hereditary dysphasic disinhibition dementia: a frontotemporal dementia linked to 17q21-22. Neurology 50:1546-1555 (Pubitemid 28283217)
37. Rosso SM, Kamphorst W, de Graaf B, Willemsen R, Ravid R, Niermeijer MF et al (2001) Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. Brain 124:1948-1957 (Pubitemid 32945896)
38. van der Zee J, Rademakers R, Engelborghs S, Gijselinck I, Bogaerts V, Vandenberghe R et al (2006) A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. Brain 129:841-852
39. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C et al (2006) Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442:916-919 (Pubitemid 44285946)
40. Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D et al (2006) Null mutations in progranulin cause ubiq-uitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442:920-924 (Pubitemid 44285947)
41. He Z, Bateman A (2003) Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med 81:600-612 (Pubitemid 37357675)
42. Zhu J, Nathan C, Jin W, Sim D, Ashcroft GS, Wahl SM et al (2002) Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 111:867-878 (Pubitemid 36106407)
43. Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J (2006) Mutations in progranulin are a major cause of ubiqui-tin-positive frontotemporal lobar degeneration. Hum Mol Genet 15:2988-3001 (Pubitemid 44530703)
44. Mackenzie IR, Neumann M, Baborie A, Sampathu DM, DuPlessis D, Jaros E et al (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122(1):111-113
45. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT et al (2006) Ubiquitinated TDP-43 in fronto-temporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130-133 (Pubitemid 44547757)
46. Snowden JS, Pickering-Brown SM, Mackenzie IR, Richardson AM, Varma A, Neary D, Mann DM (2006) Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia. Brain 129:3091-3102 (Pubitemid 44684528)
47. Yu CE, Bird TD, Bekris LM, Montine TJ, Leverenz JB, Steinbart E et al (2010) The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol 67:161-170
48. Carecchio M, Fenoglio C, De Riz M, Guidi I, Comi C, Cortini F et al (2009) Progranulin plasma levels as potential biomarker for the identification of GRN deletion carriers. A case with atypical onset as clinical amnestic mild cognitive impairment converted to Alzheimer's disease. J Neurol Sci 287:291-293
49. Carecchio M, Fenoglio C, Cortini F, Comi C, Benussi L, Ghidoni R et al (2011) Cerebrospinal fluid biomarkers in progran-ulin mutations carriers. J Alzheimers Dis 27(4):781-790
50. Pietroboni AM, Fumagalli GG, Ghezzi L, Fenoglio C, Cortini F, Serpente M et al (2011) Phenotypic heterogeneity of the GRN Asp22 fs mutation in a large Italian kindred. J Alzheimers Dis 24:253-259
51. Rainero I, Rubino E, Negro E, Gallone S, Galimberti D, Gentile S et al (2011) Heterosexual pedophilia in a frontotemporal dementia patient with a mutation in the progranulin gene. Biol Psychiatry 70:43-44
52. Cerami C, Marcone A, Galimberti D, Villa C, Scarpini E, Cappa SF (2011) From genotype to phenotype: two cases of genetic frontotemporal lobar degeneration with premorbid bipolar disorder. J Alzheimers Dis 27(4):791-797
53. Ghidoni R, Benussi L, Glionna M, Franzoni M, Binetti G (2008) Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. Neurology 71:1235-1239
54. Finch N, Baker M, Crook R, Swanson K, Kuntz K, Surtees R et al (2009) Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 132:583-591
55. Hosler BA, Siddique T, Sapp PC, Sailor W, Huang MC, Hossain A et al (2000) Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. JAMA 284:1664-1669
56. Vance C, Rogelj B, Hortobágyi T, De Vos KJ, Nishimura AL, Sreedharan J et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323:1208-1211
57. Le Ber I, Camuzat A, Hannequin D, Pasquier F, Guedj E, Rovelet-Lecrux A et al (2008) Phenotype variability in pro-granulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain 131:732-746 (Pubitemid 351294727)
58. Morita M, Al-Chalabi A, Andersen PM, Hosler B, Sapp P, Englund E et al (2006) A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology 66:839-844 (Pubitemid 43739757)
59. Rollinson S, Mead S, Snowden J, Richardson A, Rohrer J, Halliwell N (2011) Frontotemporal lobar degeneration genome wide association study replication confirms a risk locus shared with amyotrophic lateral sclerosis. Neurobiol Aging 32:758e1-758e7
60. Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D et al (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin containing protein. Nat Genet 36:377-381 (Pubitemid 38437260)
61. Kimonis VE, Fulchiero E, Vesa J, Watts G (2008) VCP disease associated with myopathy, Paget disease of bone and fronto-temporal dementia: review of a unique disorder. Biochim Bio-phys Acta 1782:744-748
62. Skibinski G, Parkinson NJ, Brown JM, Chakrabarti L, Lloyd SL, Hummerich H et al (2005) Mutations in the endosomal ESC-RTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 37:806-808 (Pubitemid 41077105)
63. Holm IE, Englund E, Mackenzie IR, Johannsen P, Isaacs AM (2007) A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3. J Neuropathol Exp Neurol 66:884-891 (Pubitemid 47530827)
64. Gydesen S, Brown JM, Brun A, Chakrabarti L, Gade A, Johannsen P et al (2002) Chromosome 3 linked frontotemporal dementia (FTD-3). Neurology 59:1585-1594 (Pubitemid 35387067)
65. Parkinson N, Ince PG, Smith MO, Highley R, Skibinski G, Andersen PM et al (2006) ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 67:1074-1077 (Pubitemid 44454610)
66. Pesiridis G, Lee VMY, Trojanowski JQ (2009) Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Hum Mol Gen 18:R156-R162
67. Benajiba L, Le Ber I, Camuzat A, Lacoste M, Thomas-Anterion C, Couratier P et al (2009) TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol 65:470-473
68. Borroni B, Bonvicini C, Alberici A, Buratti E, Agosti C, Archetti S et al (2009) Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Human Mutat 30:E974-E983
69. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C et al (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323:1205-1208
70. Chiò A, Restagno G, Brunetti M, Ossola I, Calvo A, Mora G et al (2009) Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation. Neurobiol Aging 30:1272-1275
71. Groen EJ, van Es MA, van Vught PW, Spliet WG, van Engelen-Lee J, de Visser M et al (2010) FUS mutations in familial amyotrophic lateral sclerosis in the Netherlands. Arch Neurol 67:224-230
72. Van Langenhove T, van der Zee J, Sleegers K, Engelborghs S, Vandenberghe R, Gijselinck I et al (2010) Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology 74:366-371
73. Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, Siddique N et al (2011) Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477:211-215
74. Bernardi L, Maletta RG, Tomaino C, Smirne N, Di Natale M, Perri M et al (2006) The effects of APOE and tau gene variability on risk of frontotemporal dementia. Neurobiol Aging 27:702-709
75. Fabre SF, Forsell C, Viitanen M, Sjögren M, Wallin A, Blennow K et al (2001) Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations. Exp Neurol 168:413-418 (Pubitemid 32289777)
76. Farrer LA, Abraham CR, Volicer L, Foley EJ, Kowall NW, McKee AC, Wells JM (1995) Allele epsilon 4 of apolipoprotein E shows a dose effect on age at onset of Pick disease. Exp Neurol 136:162-170 (Pubitemid 3015685)
77. Gustafson L, Abrahamson M, Grubb A, Nilsson K, Fex G (1997) Apolipoprotein-E genotyping in Alzheimer's disease and fron-totemporal dementia. Dement Geriatr Cogn Disord 8:240-243 (Pubitemid 27243709)
78. Helisalmi S, Linnaranta K, Lehtovirta M, Mannermaa A, Heinonen O, Ryynänen M et al (1996) Apolipoprotein E polymorphism in patients with different neurodegenerative disorders. Neurosci Lett 205:61-64 (Pubitemid 26062227)
79. Stevens M, van Duijn CM, de Knijff P, van Broeckhoven C, Heutink P, Oostra BA et al (1997) Apolipoprotein E gene and sporadic frontal lobe dementia. Neurology 48:1526-1529
80. Geschwind D, Karrim J, Nelson SF, Miller B (1998) The apo-lipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia. Ann Neurol 44:134-138 (Pubitemid 28323665)
81. Riemenschneider M, Diehl J, Müller U, Förstl H, Kurz A (2002) Apolipoprotein E polymorphism in German patients with fron-totemporal degeneration. J Neurol Neurosurg Psychiatry 72:639-641 (Pubitemid 34462820)
82. Short RA, Graff-Radford NR, Adamson J, Baker M, Hutton M (2002) Differences in tau and apolipoprotein E polymorphism frequencies in sporadic frontotemporal lobar degeneration syndromes. Arch Neurol 59:611-615 (Pubitemid 34289965)
83. Srinivasan R, Davidson Y, Gibbons L, Payton A, Richardson AM, Varma A et al (2006) The apolipoprotein E epsilon4 allele selectively increases the risk of frontotemporal lobar degeneration in males. J Neurol Neurosurg Psychiatry 77:154-158 (Pubitemid 43220833)
84. Forman MS, Farmer J, Johnson JK, Clark CM, Arnold SE, Coslett HB et al (2006) Frontotemporal dementia: clinicopath-ological correlations. Ann Neurol 59(6):952-962
85. Engelborghs S, Dermaut B, Goeman J, Saerens J, Mariën P, Pickut BA et al (2003) Prospective Belgian study of neurode-generative and vascular dementia: APOE genotype effects. J Neurol Neurosurg Psychiatry 74:1148-1151
86. Verpillat P, Camuzat A, Hannequin D, Thomas-Anterion C, Puel M, Belliard S et al (2002) Apolipoprotein E gene in fron-totemporal dementia: an association study and meta-analysis. Eur J Hum Genet 10:399-405
87. Conrad C, Andreadis A, Trojanowski JQ, Dickson DW, Kang D, Chen X et al (1997) Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 41:277-281 (Pubitemid 27082112)
88. Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J et al (1999) Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 8:711-715 (Pubitemid 29139987)
89. Di Maria E, Tabaton M, Vigo T, Abbruzzese G, Bellone E, Donati C et al (2000) Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann Neurol 47:374-377 (Pubitemid 30141849)
90. Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z, Lincoln SJ et al (2008) Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP-43-positive frontotemporal dementia. Human Mol Genet 17:3631-3642
91. 0UTR rs5848 in frontotemporal lobar degeneration. Neurobiol Aging 32: 754-755
92. Galimberti D, Fenoglio C, Cortini F, Serpente M, Venturelli E, Villa C et al (2010) GRN variability contributes to sporadic fron-totemporal lobar degeneration. J Alzheimers Dis 19:171-177
93. Galimberti D, Venturelli E, Villa C, Fenoglio C, Clerici F, Marcone A et al (2009) MCP-1 A-2518G polymorphism: effect on susceptibility for frontotemporal lobar degeneration and on cerebrospinal fluid MCP-1 levels. J Alzheimers Dis 17:125-133
94. Venturelli E, Villa C, Fenoglio C, Clerici F, Marcone A, Ghidoni R et al (2009) The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration. Eur J Neurol 16:37-42
95. Venturelli E, Villa C, Scarpini E, Fenoglio C, Guidi I, Lovati C et al (2008) Neuronal nitric oxide synthase C276T polymorphism increases the risk for frontotemporal lobar degeneration. Eur J Neurol 15:77-81 (Pubitemid 350265288)
96. Venturelli E, Villa C, Fenoglio C, Clerici F, Marcone A, Benussi L et al (2011) BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's disease. J Alzheimers Dis 23:701-707
97. Venturelli E, Villa C, Fenoglio C, Clerici F, Marcone A, Benussi L et al (2010) Is KIF24 a genetic risk factor for frontotemporal lobar degeneration? Neurosci Lett 482:240-244
98. Villa C, Venturelli E, Fenoglio C, Clerici F, Marcone A, Benussi L et al (2009) DCUN1D1 is a risk factor for frontotemporal lobar degeneration. Eur J Neurol 16:870-873
99. Stefani F, Zhang L, Taylor S, Donovan J, Rollinson S, Doyotte A et al (2011) UBAP1 is a component of an endosome-specific ESCRT-I complex that is essential for MVB sorting. Curr Biol 21(14):1245-1250
100. Van Deerlin VM, Sleiman PM, Martinez-Lage M, Chen-Plotkin A, Wang LS, Graff-Radford NR et al (2010) Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet 42:234-239
101. van der Zee J, Van Langenhove T, Kleinberger G, Sleegers K, Engelborghs S, Vandenberghe R et al (2011) TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort. Brain 134:808-815
102. Carrasquillo MM, Nicholson AM, Finch N, Gibbs JR, Baker M, Rutherford NJ et al (2010) Genome-wide screen identifies rs646776 near sortilin as a regulator of progranulin levels in human plasma. Am J Hum Genet 87:890-897
103. Riedijk SR, Niermeijer MFN, Dooijes D, Tibben A (2009) A decade of genetic counseling in frontotemporal dementia affected families: few counselling requests and much familial opposition to testing. J Genet Counsel 18:350-356